June 2021 COVID-19 and Mucormycosis Research Round Up

1/1

All the research related to mucormycosis and COVID-19 published in June 2021, sourced from LitCovid.

Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino orbital-cerebral mucormycosis in 2826 patients in India Collaborative OPAI-JO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. https://doi.org/10.4103/ijo.IJO_1565_21
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India. Emerg Infect Dis. https://doi.org/10.3201/eid2709.210934
Case reports in India
Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the north western part of India. Indian J Med Microbiol. https://doi.org/10.1016/j.ijmmb.2021.05.009
Autoptic identification of disseminated mucormycosis in a young male presenting with cerebrovascular event, multi- organ dysfunction and COVID-19 infection. IDCases. https://doi.org/10.1016/j.idcr.2021.e01172
Mucormycosis A Dreaded Complication Of Covid-19. QJM. https://doi.org/10.1093/qjmed/hcab166
Mucormycosis in post-COVID-19 renal transplant patients: A lethal complication in follow-up. Transpl Infect Dis. https://doi.org/10.1111/tid.13663

COVID-19 associated Mucormycosis: An epidemic within a pandemic. QJM. https://doi.org/10.1093/qimed/hcab165
Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgrad Med J. https://doi.org/10.1136/postgradmedj 2021-140537
The “Black Fungus” in India: The Emerging Syndemic of COVID-19-Associated Mucormycosis. Ann Intern Med. https://doi.org/10.7326/M21 2354
Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Lancet Respir Med.https://doi.org/10.1016/S2213-2600(21)00265-4
COVID-19 and Mucormycosis Syndemic: Double Health Threat to a Collapsing Healthcare System in India. Trop Med Int Health. https://doi.org/10.1111/tmi.13641
Mucormycosis: A killer in the shadow of COVID-19. J Mycol Med. https://doi.org/10.1016/j.mycmed.2021.101161
The “black fungus” through a gray lens: Imaging COVID-19-associated mucormycosis. Indian J Ophthalmol. https://doi.org/10.4103/ijo.IJO_1506_21
The emergence of post-COVID-19 mucormycosis in India: Can we prevent it? Indian J Ophthalmol. https://doi.org/10.4103/ijo.IJO_1392_21

Does COVID 19 generate a milieu for propagation of mucormycosis? Med Hypotheses. https://doi.org/10.1016/j.mehy.2021.110613
Magnetic resonance imaging in rhino-orbital-cerebral mucormycosis. Indian J Ophthalmol. https://doi.org/10.4103/ijo.IJO_1439_21
CT and MRI Findings of Invasive Mucormycosis in the Setting of COVID-19: Experience From A Single Center in India. A/R Am J Roentgenol. https://doi.org/10.2214/AJR.21.26205
Current Understanding in the Pathophysiology of SARS-CoV-2-Associated Rhino-Orbito-Cerebral Mucormycosis: A Comprehensive Review. J Maxillofac Oral Surg. https://doi.org/10.1007/s12663-021-01604-2

Prevention of mucormycosis in COVID-19 the need of the hour. Indian J Ophthalmol.https://doi.org/10.4103/ijo.IJO_1200_21
COVID-19, steroids, and mucormycosis: What an ophthalmologist should know. Indian J Ophthalmol. https://doi.org/10.4103/ijo.UJO_1143_21

Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicenter study from Iran. Mycoses. https://doi.org/10.1111/myc.13334
Case series of four secondary mucormycosis infections in COVID 19 patients, the Netherlands, December 2020 to May 2021. Euro Surveill. https://doi.org/10.2807/1560-7917.ES.2021.26.23.2100510
Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Jpn J Ophthalmol. https://doi.org/10.1007/s10384-021-00845-5
Spike in Rhino-Orbital-Cerebral Mucormycosis Cases Presenting to a Tertiary Care Center During the COVID-19 Pandemic. Front Med (Lausanne). https://doi.org/10.3389/fmed.2021.64527C

Photo credit: Sunita Kuwar KC